We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). The accrual ratio subtracts the FCF from ...

The latest price target for 10x Genomics (NASDAQ:TXG) was reported by Morgan Stanley on May 19, 2025. The analyst firm set a price target for $18.00 expecting TXG to rise to within 12 months (a ...

10x Genomics Inc (NASDAQ:TXG) reported total revenue of $155 million for Q1 2025, with strong performance in consumables indicating robust core demand. The company settled worldwide patent ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded. After speakers ...

The vivo Y300 series just got its latest member with the Y300 GT. The device was announced in China and features similar specs to the recently announced iQOO Z10 Turbo. Y300 GT features a 6.78 ...

For the quarter ended March 2025, 10x Genomics (TXG) reported revenue of $154.88 million, up 9.8% over the same period last year. EPS came in at -$0.36, compared to -$0.50 in the year-ago quarter.